Testosterone monotherapy is not an effective treatment for clinical depressive disorders in hypogonadal men and should not be used for that purpose. Consider this when a patient presents with depressive mood and low testosterone, questioning whether testosterone will improve depression or if depression should be treated separately.
Scanned 9/9/2026
Install to Claude Code
npx -y skills add dromlakhani/MD2SKILL --skill icsm-avoid-tt-for-depressive-disorders --agent claude-codeInstalls into .claude/skills of the current project.
Are you the author of Icsm Avoid Tt For Depressive Disorders?
Add the live security badge to your README — it updates automatically with every re-scan.
[](https://www.skillsdirectory.com/skills/dromlakhani-icsm-avoid-tt-for-depressive-disorders)More formats (shields.io, HTML) on the badges page.
---
name: icsm-avoid-tt-for-depressive-disorders
description: Testosterone monotherapy is not an effective treatment for clinical depressive disorders in hypogonadal men and should not be used for that purpose. Consider this when a patient presents with depressive mood and low testosterone, questioning whether testosterone will improve depression or if depression should be treated separately.
---
# Avoid testosterone therapy alone for treating clinical depressive disorders
## STEP 1 — Gather Information
Collect a structured depression assessment (e.g., PHQ-9), morning total testosterone level (fasting, 07:00–11:00), and document hypogonadism symptoms (low libido, erectile dysfunction, fatigue, decreased vigor). Rule out medical mimics of depression (thyroid disorders, anemia, medication effects).
## STEP 2 — Rule In / Rule Out
Is a clinical depressive disorder diagnosed per DSM-5/ICD-10 criteria? If YES, proceed to Step 3; if NO, consider testosterone therapy for hypogonadism symptoms (if confirmed) and manage accordingly.
## STEP 3 — Classify or Stratify
Classify depression severity using PHQ-9: mild (5–9), moderate (10–14), moderately severe (15–19), severe (20–27). If mild, consider psychotherapy or watchful waiting; if moderate-severe or greater, initiate evidence-based antidepressant therapy or refer to mental health specialist.
## STEP 4 — Decide
Do not prescribe testosterone monotherapy for depression; treat depression with guideline-concordant antidepressants/psychotherapy, and consider testosterone therapy only for hypogonadism symptoms after depressive disorder is adequately treated.
## Clinical Guardrails / Mimics / Pitfalls
Do not attribute depressive symptoms solely to low testosterone; avoid using TTh as a sole antidepressant; monitor for worsening depression or emergent suicidality; ensure depression is treated per psychiatric guidelines before addressing hypogonadism.
## Concrete Clinical Example
A 52-year-old man reports fatigue, low libido, and morning total testosterone 8 nmol/L. PHQ-9 score is 15 (moderately severe depression). He asks if testosterone will improve his mood. According to the guideline, do not start testosterone therapy alone; initiate an SSRI, reassess mood in 4–6 weeks, and consider testosterone only for hypogonadism if depressive symptoms remit.
**Source:** Male hypogonadism: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024), Box2 Recommendation 14, 2025, https://doi.org/10.1093/sxmrev/qeaf036
Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.
No comments yet. Be the first to comment!